Login/Sign Up
₹8535.4*
MRP ₹10409
18% off
₹8847.65*
MRP ₹10409
15% CB
₹1561.35 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Leupo-11.25 mg Injection 1's to avoid unpleasant side-effects. Alcohol intake, along with Leupo-11.25 mg Injection 1's, may cause increased drowsiness.
Pregnancy
Unsafe
Leupo-11.25 mg Injection 1's is a pregnancy category X drug. Leupo-11.25 mg Injection 1's should not be used during pregnancy because it causes harm to the fetus (newborn baby). Both women of childbearing potential and men must use an effective method of contraception while taking fluorouracil and for at least 6 months afterwards. Please consult your doctor about any concerns regarding this.
Breast Feeding
Unsafe
Leupo-11.25 mg Injection 1's should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers.
Driving
Caution
Leupo-11.25 mg Injection 1's causes dizziness and affects your ability to drive. Do not drive or operate machinery if you experience any unmanageable side effects with Leupo-11.25 mg Injection 1's.
Liver
Caution
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking Leupo-11.25 mg Injection 1's. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Kidney
Caution
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking Leupo-11.25 mg Injection 1's. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Children
Caution
Leupo-11.25 mg Injection 1's is not recommended in children younger than two years of age.
Product Substitutes
About Leupo-11.25 mg Injection 1's
Leupo-11.25 mg Injection 1's belongs to the class of 'anticancer or anti-neoplastic agents', primarily used to treat prostate cancer in men, breast cancer and endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Breast cancer is a type of cancer that develops in breast cells stimulated by a female sex hormone called oestrogen. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon.
Leupo-11.25 mg Injection 1's contains Leuprolide that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. It is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis and breast cancer in women.
Take Leupo-11.25 mg Injection 1's as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Leupo-11.25 mg Injection 1's include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site pain reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
To treat your condition effectually continue taking Leupo-11.25 mg Injection 1's for as long as your doctor has prescribed. Do not stop Leupo-11.25 mg Injection 1's midway. Avoid taking Leupo-11.25 mg Injection 1's if you are pregnant or breastfeeding because this Leupo-11.25 mg Injection 1's can cause harmful effects on the unborn baby. Both women and men using this Leupo-11.25 mg Injection 1's should use birth control to avoid pregnancy. Leupo-11.25 mg Injection 1's may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Leupo-11.25 mg Injection 1's is not recommended for children below two years of age. Leupo-11.25 mg Injection 1's may make you feel dizzy, hence drive when you are alert only.
Uses of Leupo-11.25 mg Injection 1's
Medicinal Benefits
Leupo-11.25 mg Injection 1's contains Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Leupo-11.25 mg Injection 1's is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, Leupo-11.25 mg Injection 1's works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Leupo-11.25 mg Injection 1's reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis and breast cancer.
Directions for Use
Side Effects of Leupo-11.25 mg Injection 1's
Drug Warnings
If you are allergic to Leupo-11.25 mg Injection 1's or any other medicines, please tell your doctor. Leupo-11.25 mg Injection 1's can affect the unborn baby when used in pregnancy. Hence, Leupo-11.25 mg Injection 1's is not indicated for use in pregnancy and breastfeeding women. If you are using Leupo-11.25 mg Injection 1's, make sure to use reliable forms of contraception to prevent pregnancy during the course. Leupo-11.25 mg Injection 1's may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Use the Leupo-11.25 mg Injection 1's with caution in elderly patients and children. Leupo-11.25 mg Injection 1's is not recommended for children younger than two years of age. Your symptoms may become temporarily worse when you first start taking Leupo-11.25 mg Injection 1's. Inform your doctor if this continues for longer than 2 months. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Leupo-11.25 mg Injection 1's, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Leupo-11.25 mg Injection 1's may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Leupo-11.25 mg Injection 1's. Leupo-11.25 mg Injection 1's can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise